Zheng Quan Shi Bao Wang·2025-07-14 13:45Core Viewpoint - China National Chemical Equipment (中化装备) plans to initiate an asset injection from its major shareholder, which is expected to constitute a significant asset restructuring after completing a major asset divestiture and entering a business adjustment period [1]. Group 1: Asset Injection Details - On July 14, China National Chemical Equipment announced plans to issue shares to acquire 100% equity of Yiyang Rubber Plastic Machinery Group Co., Ltd. and 100% equity of Blue Star (Beijing) Chemical Machinery Co., Ltd. from China Chemical Equipment Co., Ltd. and Blue Star Energy Investment Management Co., Ltd. respectively, while also raising matching funds from no more than 35 qualified investors [2]. - The company has signed a Letter of Intent for Equity Acquisition with relevant parties for both transactions, agreeing to further negotiate on the scope of the acquired assets, transaction methods, pricing, and asset valuation [4]. Group 2: Business Synergy - The injected assets are expected to have business synergy with China National Chemical Equipment. Yiyang Rubber Machinery is a key player in the domestic rubber machinery industry, with products sold to over 40 countries, including Japan, the USA, and Brazil [5]. - Blue Star Machinery, a high-tech enterprise, is one of the three major global suppliers of ion membrane electrolytic cells, with a domestic market share of nearly 50% and an international market share exceeding 20% by the end of 2024 [5]. Group 3: Financial Performance - China National Chemical Equipment has faced continuous losses in recent years, but the loss amount has significantly narrowed after asset divestiture. The company expects a net loss attributable to shareholders of approximately 14.71 million to 22.06 million yuan for the first half of 2025 [6]. - The company anticipates improved financial conditions after completing the major asset restructuring project by the end of December 2024, as overseas loss-making businesses will no longer be included in the consolidated financial statements [6].